20,000 Avandia Lawsuits Settled

Recent news has surfaced in the controversial case surrounding the diabetes medication Avandia. GlaxoSmithKline, the company who marketed the medication, is paying $3 billion to resolve the whole thing. The settlement would resolve more than 20,000 cases of Avandia-related side effects such as heart attacks. It looks like Glaxo wants a clean slate, and this settlement is part of their effort to do so. Glaxo even previously agreed to pay $700 million to settle 15,000 claims last year.

The remaining cases had a 75-day deadline for them to be resolved, but it is unclear if that goal has been met. No Avandia cases have yet come before a jury. In 2010 Glaxo agreed to stop promoting the drug worldwide after regulators banned it from Europe's market and severely decreased its sale in the United States. Avandia used to make a $3 billion profit in one year alone, but after the claims started pouring in, it decreased by 43%. The $3 billion settlement is going toward stopping government probing of their marketing practices.

Avandia was a part of many American's daily routines. They relied on this medication to survive with diabetes, but in many, it actually increased their risk of health complications. As pharmaceutical injury attorneys, we have dealt with countless other dangerous drugs cases just like yours and know what it takes to get you the justice you deserve after suffering an injury or losing a loved one after taking Avandia. If you have taken Avandia and have suffered health complications because of it, don't hesitate to contact a pharmaceutical injury lawyer from Arnold & Itkin today.